Consequences of imprecision in fetal fraction estimation on performance of cell-free DNA screening for Down syndrome
Persson F. and Cuckle H.S., Prenat Diagn. 2022
Articles and resources
Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study)
Pooh, R.K.; Masuda, C.; Matsushika, R.; Machida, M.; Nakamura, T.; Takeda, M.; Ohashi, H.; Kumagai, M.; Uenishi, K.; Roos, F.; Persson, F.; Shimokawa, O. Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study). Diagnostics 2021, 11, 1837. https://doi.org/10.3390/diagnostics11101837
Performance of commercially available placental growth factor tests in women with suspected preterm pre‐eclampsia; the COMPARE study
F.P. McCarthy et. al. Ultrasound in Obstetrics & Gynecology
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
David Wright et. al. The American Journal of Obstetrics & Gynecology
Aspirin versus Placebo in Pregnancies at high Risk for Preterm Preeclampsia
Daniel L. Rolnik et. al. The New England Journal of Medicine
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)
Persson et al., Clinical Chemistry, 2021
Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
Huang et al., BMC Pregnancy and Childbirth, 2020. Provided by the Springer Nature SharedIt content-sharing initiative. No modifications were made on this material. https://creativecommons.org/licenses/by/4.0/
Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma
Ericsson et al., Prenatal Diagnosis. 2019
Imaging single DNA molecules for high precision NIPT
Dahl et al., Scientific Reports, 2018
Products may not be licensed in accordance with the laws in all countries, such as the United States, Canada. Please check with your local representative for availability.
Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.
